The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Disease progression among patients who receive available bladder preservation therapies after failure of BCG therapy in the SEER-Medicare data.
Ashish M. Kamat
Honoraria - AstraZeneca (I); Tesaro (I)
Consulting or Advisory Role - Abbott Molecular; Arquer Diagnostics; Bristol-Myers Squibb; CG Oncology; Eisai; Ferring; Heat Biologics; Imagin Medical; Merck; Photocure; Theralase; US Biotest
Research Funding - Bristol-Myers Squibb; FKD Therapies; Heat Biologics; Merck; Photocure
Patents, Royalties, Other Intellectual Property - Patent: CyPRIT (Cytokine Predictors of Response to Intravesical Therapy) joint with UT MD Anderson Cancer Center
Other Relationship - International Bladder Cancer Group (IBCG)
Mihaela V. Georgieva
Consulting or Advisory Role - Ferring (Inst)
Jinlin Song
Consulting or Advisory Role - Ferring (Inst)
Iryna Bocharova
Consulting or Advisory Role - Ferring (Inst)
Kun Qian
Consulting or Advisory Role - Ferring (Inst)
Amy Guo
Employment - Ferring
Min Yang
Consulting or Advisory Role - Ferring (Inst)
Research Funding - Ferring (Inst)